Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Forster

Showing results (371-380 of 389) with videos related to

Pageof 39
Sort By:
Cell Reports|April 20, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Cell Reports|January 5, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Cancer|March 27, 2014
Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumorsAnthony E Rizzardi, Rachel Isaksson Vogel, Joseph S Koopmeiners, et al.
Cell Reports|June 9, 2015
Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by SequestrationPeng Liu, Miranda N Reed, Linda A Kotilinek, et al.
Molecular Cancer Research : MCR|March 2, 2021
Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene FusionsJong Hyuk Kim, Kate Megquier, Rachael Thomas, et al.
Molecular Cancer Therapeutics|February 15, 2017
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPARAntonella Borgatti, Joseph S Koopmeiners, Aaron L Sarver, et al.
Cancer Discovery|March 29, 2013
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceAdrienne L Watson, Eric P Rahrmann, Branden S Moriarity, et al.
The Journal of Pathology|May 15, 2023
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patientsSarah E Tarullo, Yuyu He, Claire Daughters, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
Pageof 39

Showing results (371-380 of 389) with videos related to

Sort By:
Pageof 39
Cell Reports|April 20, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Cell Reports|January 5, 2017
Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelRebecca L Klank, Stacy A Decker Grunke, Benjamin L Bangasser, et al.
Cancer|March 27, 2014
Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumorsAnthony E Rizzardi, Rachel Isaksson Vogel, Joseph S Koopmeiners, et al.
Cell Reports|June 9, 2015
Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by SequestrationPeng Liu, Miranda N Reed, Linda A Kotilinek, et al.
Molecular Cancer Research : MCR|March 2, 2021
Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene FusionsJong Hyuk Kim, Kate Megquier, Rachael Thomas, et al.
Molecular Cancer Therapeutics|February 15, 2017
Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPARAntonella Borgatti, Joseph S Koopmeiners, Aaron L Sarver, et al.
Cancer Discovery|March 29, 2013
Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenanceAdrienne L Watson, Eric P Rahrmann, Branden S Moriarity, et al.
The Journal of Pathology|May 15, 2023
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patientsSarah E Tarullo, Yuyu He, Claire Daughters, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 7, 2025
Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activityAshley J Schulte, Mitzi Lewellen, Willa Durose, et al.
Cancer Research Communications|May 17, 2024
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic ExpansionJong Hyuk Kim, Ashley J Schulte, Aaron L Sarver, et al.
Pageof 39